• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的 RNA 靶向药物发现的新见解。

Novel insights of structure-based modeling for RNA-targeted drug discovery.

机构信息

Integrated Molecular Discovery Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1901 East Road, Houston Texas 77054, USA.

出版信息

J Chem Inf Model. 2012 Oct 22;52(10):2741-53. doi: 10.1021/ci300320t. Epub 2012 Sep 21.

DOI:10.1021/ci300320t
PMID:22947071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3869234/
Abstract

Substantial progress in RNA biology highlights the importance of RNAs (e.g., microRNAs) in diseases and the potential of targeting RNAs for drug discovery. However, the lack of RNA-specific modeling techniques demands the development of new tools for RNA-targeted rational drug design. Herein, we implemented integrated approaches of accurate RNA modeling and virtual screening for RNA inhibitor discovery with the most comprehensive evaluation to date of five docking and 11 scoring methods. For the first time, statistical analysis was heavily employed to assess the significance of our predictions. We found that GOLD:GOLD Fitness and rDock:rDock_solv could accurately predict the RNA ligand poses, and ASP rescoring further improved the ranking of ligand binding poses. Due to the weak correlations (R(2) < 0.3) of existing scoring with experimental binding affinities, we implemented two new RNA-specific scoring functions, iMDLScore1 and iMDLScore2, and obtained better correlations with R(2) = 0.70 and 0.79, respectively. We also proposed a multistep virtual screening approach and demonstrated that rDock:rDock_solv together with iMDLScore2 rescoring obtained the best enrichment on the flexible RNA targets, whereas GOLD:GOLD Fitness combined with rDock_solv rescoring outperformed other methods for rigid RNAs. This study provided practical strategies for RNA modeling and offered new insights into RNA-small molecule interactions for drug discovery.

摘要

在 RNA 生物学领域取得了重大进展,突显了 RNA(例如 microRNAs)在疾病中的重要性,以及针对 RNA 进行药物发现的潜力。然而,缺乏 RNA 特异性建模技术要求开发新的工具,用于针对 RNA 的合理药物设计。在此,我们实施了综合的 RNA 精确建模和虚拟筛选方法,对迄今为止的五种对接和十一种评分方法进行了最全面的评估。首次,我们大量使用统计分析来评估我们的预测的重要性。我们发现,GOLD:GOLD Fitness 和 rDock:rDock_solv 可以准确预测 RNA 配体的构象,而 ASP 重新评分进一步提高了配体结合构象的排名。由于现有评分与实验结合亲和力之间的相关性较弱(R(2) < 0.3),我们实施了两个新的 RNA 特异性评分函数,iMDLScore1 和 iMDLScore2,它们分别与 R(2) = 0.70 和 0.79 具有更好的相关性。我们还提出了一种多步虚拟筛选方法,并证明 rDock:rDock_solv 与 iMDLScore2 重新评分相结合,可以更好地富集柔性 RNA 靶标,而 GOLD:GOLD Fitness 与 rDock_solv 重新评分相结合则优于其他方法,用于刚性 RNA。这项研究为 RNA 建模提供了实用策略,并为药物发现中的 RNA-小分子相互作用提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/35a5057aa739/nihms513464f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/7a5f339fd72a/nihms513464f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/3a626718075a/nihms513464f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/7f7b63552786/nihms513464f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/0a2291b5eb97/nihms513464f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/82db48ade7ca/nihms513464f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/35a5057aa739/nihms513464f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/7a5f339fd72a/nihms513464f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/3a626718075a/nihms513464f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/7f7b63552786/nihms513464f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/0a2291b5eb97/nihms513464f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/82db48ade7ca/nihms513464f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d849/3869234/35a5057aa739/nihms513464f6.jpg

相似文献

1
Novel insights of structure-based modeling for RNA-targeted drug discovery.基于结构的 RNA 靶向药物发现的新见解。
J Chem Inf Model. 2012 Oct 22;52(10):2741-53. doi: 10.1021/ci300320t. Epub 2012 Sep 21.
2
Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.通过使用 MM-GBSA 对多个 X 射线蛋白质构象中的配体构象进行重新排序,从而提高对接结果。
J Chem Inf Model. 2014 Oct 27;54(10):2697-717. doi: 10.1021/ci5003735. Epub 2014 Sep 30.
3
Negative Image-Based Screening: Rigid Docking Using Cavity Information.基于负图像的筛选:利用腔信息进行刚性对接。
Methods Mol Biol. 2021;2266:125-140. doi: 10.1007/978-1-0716-1209-5_7.
4
Beware of machine learning-based scoring functions-on the danger of developing black boxes.警惕基于机器学习的评分函数——开发黑盒的危险。
J Chem Inf Model. 2014 Oct 27;54(10):2807-15. doi: 10.1021/ci500406k. Epub 2014 Sep 24.
5
Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.通过基于结构的层次虚拟筛选发现新型微管蛋白抑制剂。
J Chem Inf Model. 2012 Oct 22;52(10):2730-40. doi: 10.1021/ci300302c. Epub 2012 Oct 2.
6
Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.迈向全自动高性能计算药物发现:一种大规模并行虚拟筛选管道,用于对接和分子力学/广义 Born 表面面积再评分,以提高富集度。
J Chem Inf Model. 2014 Jan 27;54(1):324-37. doi: 10.1021/ci4005145. Epub 2014 Jan 3.
7
Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.快速重评分协议可改善基于结构的蛋白质-蛋白质界面虚拟筛选的性能。
J Chem Inf Model. 2020 Aug 24;60(8):3910-3934. doi: 10.1021/acs.jcim.0c00545. Epub 2020 Aug 11.
8
Assessing the performance of MM/PBSA and MM/GBSA methods. 10. Prediction reliability of binding affinities and binding poses for RNA-ligand complexes.评估 MM/PBSA 和 MM/GBSA 方法的性能。10. RNA-配体复合物结合亲和力和结合构象的预测可靠性。
Phys Chem Chem Phys. 2024 Mar 27;26(13):10323-10335. doi: 10.1039/d3cp04366e.
9
An integrated virtual screening approach for VEGFR-2 inhibitors.一种针对血管内皮生长因子受体2(VEGFR-2)抑制剂的综合虚拟筛选方法。
J Chem Inf Model. 2013 Dec 23;53(12):3163-77. doi: 10.1021/ci400429g. Epub 2013 Dec 3.
10
Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening.基于负图像的重新评分:利用空洞信息改进对接筛选。
Methods Mol Biol. 2021;2266:141-154. doi: 10.1007/978-1-0716-1209-5_8.

引用本文的文献

1
Discovery of RNA-Targeting Small Molecules: Challenges and Future Directions.RNA靶向小分子的发现:挑战与未来方向
MedComm (2020). 2025 Aug 24;6(9):e70342. doi: 10.1002/mco2.70342. eCollection 2025 Sep.
2
Review on Advancement of AI in Cell Engineering and Molecular Biology.人工智能在细胞工程和分子生物学中的进展综述
Methods Mol Biol. 2025;2952:169-192. doi: 10.1007/978-1-0716-4690-8_10.
3
Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy.靶向微小RNA的小分子:精准癌症治疗中的新机遇与挑战
Trends Cancer. 2024 Sep;10(9):809-824. doi: 10.1016/j.trecan.2024.06.006. Epub 2024 Aug 5.
4
RmsdXNA: RMSD prediction of nucleic acid-ligand docking poses using machine-learning method.RmsdXNA:使用机器学习方法预测核酸-配体对接构象的 RMSD。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae166.
5
Advances in machine-learning approaches to RNA-targeted drug design.用于RNA靶向药物设计的机器学习方法的进展。
Artif Intell Chem. 2024 Jun;2(1). doi: 10.1016/j.aichem.2024.100053. Epub 2024 Feb 6.
6
RNA-ligand molecular docking: advances and challenges.RNA-配体分子对接:进展与挑战
Wiley Interdiscip Rev Comput Mol Sci. 2022 May-Jun;12(3). doi: 10.1002/wcms.1571. Epub 2021 Aug 16.
7
Comparative Assessment of Docking Programs for Docking and Virtual Screening of Ribosomal Oxazolidinone Antibacterial Agents.核糖体恶唑烷酮类抗菌剂对接及虚拟筛选中对接程序的比较评估
Antibiotics (Basel). 2023 Feb 24;12(3):463. doi: 10.3390/antibiotics12030463.
8
AnnapuRNA: A scoring function for predicting RNA-small molecule binding poses.AnnapuRNA:一种预测RNA与小分子结合构象的评分函数。
PLoS Comput Biol. 2021 Feb 1;17(2):e1008309. doi: 10.1371/journal.pcbi.1008309. eCollection 2021 Feb.
9
How 'Protein-Docking' Translates into the New Emerging Field of Docking Small Molecules to Nucleic Acids?蛋白质对接如何转化为新兴的小分子与核酸对接领域?
Molecules. 2020 Jun 13;25(12):2749. doi: 10.3390/molecules25122749.
10
Understanding the Contributions of Conformational Changes, Thermodynamics, and Kinetics of RNA-Small Molecule Interactions.理解 RNA-小分子相互作用的构象变化、热力学和动力学的贡献。
ACS Chem Biol. 2019 May 17;14(5):824-838. doi: 10.1021/acschembio.8b00945. Epub 2019 May 1.

本文引用的文献

1
Target Flexibility in RNA-Ligand Docking Modeled by Elastic Potential Grids.基于弹性势网格建模的RNA-配体对接中的靶点灵活性
ACS Med Chem Lett. 2011 Apr 12;2(7):489-93. doi: 10.1021/ml100217h. eCollection 2011 Jul 14.
2
Potential and limitations of ensemble docking.基于配体的对接方法的潜力和局限性。
J Chem Inf Model. 2012 May 25;52(5):1262-74. doi: 10.1021/ci2005934. Epub 2012 Apr 17.
3
From laptop to benchtop to bedside: structure-based drug design on protein targets.从笔记本电脑到台式机再到床边:基于结构的药物设计针对蛋白质靶标。
Curr Pharm Des. 2012;18(9):1217-39. doi: 10.2174/138161212799436386.
4
Accurate prediction of the bound form of the Akt pleckstrin homology domain using normal mode analysis to explore structural flexibility.利用正常模式分析准确预测 Akt pleckstrin 同源结构域的结合形式,以探索结构的灵活性。
J Chem Inf Model. 2011 Sep 26;51(9):2352-60. doi: 10.1021/ci2001742. Epub 2011 Aug 25.
5
Understanding the origins of bacterial resistance to aminoglycosides through molecular dynamics mutational study of the ribosomal A-site.通过核糖体 A 位的分子动力学突变研究了解细菌对氨基糖苷类药物耐药性的起源。
PLoS Comput Biol. 2011 Jul;7(7):e1002099. doi: 10.1371/journal.pcbi.1002099. Epub 2011 Jul 21.
6
Selective inhibition of MBNL1-CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2).小分子对 MBNL1-CCUG 相互作用的选择性抑制作用,为肌强直性营养不良 2 型(DM2)的潜在治疗药物提供了方向。
Nucleic Acids Res. 2011 Nov 1;39(20):8881-90. doi: 10.1093/nar/gkr415. Epub 2011 Jul 18.
7
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.通过靶向 RNA 动态组合发现选择性生物活性小分子。
Nat Chem Biol. 2011 Jun 26;7(8):553-9. doi: 10.1038/nchembio.596.
8
Novel ligands for a purine riboswitch discovered by RNA-ligand docking.通过RNA-配体对接发现的嘌呤核糖开关新型配体。
Chem Biol. 2011 Mar 25;18(3):324-35. doi: 10.1016/j.chembiol.2010.12.020.
9
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.小分子依诺沙星是一种癌症特异性生长抑制剂,通过增强 TAR RNA 结合蛋白 2 介导的 microRNA 加工起作用。
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4394-9. doi: 10.1073/pnas.1014720108. Epub 2011 Feb 28.
10
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.miRNA/TP53 反馈回路与 B 细胞慢性淋巴细胞白血病发病机制和预后的关联。
JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.